Evidence map›Paper›PMID 22679399›Full record

ArticleMolecular syndromology2012

MECP2 Duplication Syndrome.

H Van Esch

2 registry-linked trialsAbstract read
In one paragraph

Article in Molecular syndromology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02705677 completednot on this mapstarted 2017, after this paper: background citation

Biobanking of Rett Syndrome and Related Disorders Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2017 to 2021Enrolled752ConditionsRett Syndrome, MECP2 Duplication, CDKL5, FOXG1 Disorders
NCT02738281 completednot on this mapstarted 2015, after this paper: background citation

Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2015 to 2021Enrolled1,044ConditionsRett Syndrome, MECP2 Duplication dIsorder, CDKL5 Disorder, FOXG1 Syndrome
3 · Its place in the literature

Who cites it

78 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Rett and Rett-related disorders: Common mechanisms for shared symptoms?Experimental biology and medicine (Maywood, N.J.) · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. The Journal of international medical research · 2023
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Medical Comorbidities inChildren (Basel, Switzerland) · 2022
    Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

H Van EschCentre for Human Genetics, University Hospitals Leuven, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the initial report that clearly established a causal role between duplication of the MECP2 gene and a severe syndromic form of intellectual disability, many new patients have been identified and reported, and the etiology in already published families solved. This has led to the establishment of a clinically recognizable disorder. Here, we review the clinical data of 129 reported and nonreported male patients with MECP2 duplication syndrome.

Identifiers

PMID22679399
PMCPMC3366699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.